Anti-inflammatory properties of paraoxonase-1 in atherosclerosis

Advances in Experimental Medicine and Biology

Volumn 660, Issue , 2010, Pages 143-151

  MacKness, Bharti ^a   MacKness, Mike ^a  

^a NONE

Author keywords

High density lipoprotein; Inflammation; Lipid hydroperoxides; Oxidation; Paraoxonase 1; Paraoxonase 3

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ANTIINFLAMMATORY ACTIVITY; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CELL MEMBRANE; CHOLESTEROL TRANSPORT; CYTOTOXICITY; DIABETES MELLITUS; GENE OVEREXPRESSION; HUMAN; INFLAMMATION; LIPID OXIDATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION;

ANTI-INFLAMMATORY AGENTS; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; CELL MEMBRANE; DIABETES MELLITUS; ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; INFLAMMATION; LIPIDS; LIPOPROTEINS, HDL; MACROPHAGES; MODELS, BIOLOGICAL; OXYGEN;

ANIMALIA;

EID: 78049276598     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-350-3_13     Document Type: Article

References (28)

1. Ansell, B. J. , Fonarow, G. C. , Fogelman, A. M. (2007) The paradox of dysfunctional high-density lipoprotein. Curr Opin Lipidol 18: 427-434. (Pubitemid 47051922)
2. Ansell, B. J. , Navab, M. , Hama, S. , Kamranpour, N. , Fonarow, G. , Hough, G. et al. (2003) Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favourably affected by simvastatin treatment. Circulation 108: 2751-2756. (Pubitemid 37498976)
3. Arrol, S. , Mackness, M. I. , Durrington, P. N. (1996) High-density lipoprotein associated enzymes and the prevention of low-density lipoprotein oxidation. Eur J Lab Med 4: 33-38. (Pubitemid 27067961)
4. Aviram, M. , Billecke, S. , Sorenson, R. , Bisgaier, C. , Newton, R. , Rosenblat, M. , Erogul, J. , Hsu, C. , Dunlop, C. , La Du, B. N (1998) Paraoxonase active site required for protection against LDL oxidation involves its free sulphydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase alloenzymes Q and R. Arterioscl Thromb Vasc Biol 10: 1617-1624. (Pubitemid 28465415)
5. Aviram, M., Rosenblat, M. (2004) Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 37: 1304-16. (Pubitemid 39349234)
6. Feingold, K. R. ,Memon, R. A. , Moser, A. H. , Grunfeld, C. (1998) Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 139: 307-315. (Pubitemid 28361815)
7. Ferretti, G. , Bacchetti, T. , Busni, D. , Rabini, R. A. , Curatola, G. (2004) Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients. J Clin Endocrinol Metab 89: 2957-2962. (Pubitemid 38766392)
8. Liu, Y. , Mackness, B. , Mackness, M. , (2008) Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress. Free Radic Biol Med 45:743-748
9. Lusis, A. J. (2000) Atherosclerosis. Nature 407: 233-241.
10. Mackness, B. , Mackness, M. (2009) HDL -Why all the fuss? Ann Clin Biochem-46:5-7
11. Mackness, B. , Hine, D. , Liu, Y. Mastorikou, M. , Mackness, M. (2004) Paraoxonase 1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells. BBRC 318: 680-683. (Pubitemid 38624207)
12. Mackness, B. , Hine, D. , McElduff, P. , Mackness, M. (2006) High C-reactive protein and low paraoxonase 1 in diabetes as risk factors for coronary heart disease. Atherosclerosis 185: 396-401.
13. Mackness, B. , Hunt, R. , Durrington, P. N. , Mackness, M. I. (1997) Increased immunolocalisation of paraoxonase, clusterin and apolipoprotein AI in the human artery wall with progression of atherosclerosis. Arterioscler Thromb Vasc Biol 17: 1233-1238. (Pubitemid 27329844)
14. Mackness, B. , Quarck, R. , Verreth, W. , Mackness, M. , Holvoet, P. (2006a) Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome. Arterioscler Thromb Vasc Biol 26:1545-1550. (Pubitemid 44288981)
15. Mackness, M. I. , Arrol, S. & Durrington, P. N. (1991) Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Letts 286: 152-154.
16. Mackness, MI. , Durrington, PN. , Mackness, B. (2002) The role of paraoxonase in lipid metabolism. In: Costa, LG. , Furlong, CE (eds. ). Paraoxonase (PON1) in health and disease. Norwell, MA: Kluwer.
17. Marathe, G. K. , Zimmerman, G. A. , McIntyre, T. M. (2003) Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles. J Biol Chem 278: 3937-3947. (Pubitemid 36801125)
18. Marsillach, J. , Mackness, B. , Mackness, M. , Riu, F. , Beltran, R. , Joven, J. , Camps, J. (2008) Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues. Free Rad Biol Med 45: 146-157.
19. Mastorikou, M. , Mackness, B. , Liu, Y. , Mackness, M. (2008) Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolise membrane lipid hydroperoxides. Diabetic Med 25: 1049-1055.
20. Mastorikou, M. , Mackness, M. , Mackness, B. (2006) Defective metabolism of oxidisedphospholipid by high-density lipoprotein from people with type 2 diabetes. Diabetes 55: 3099-3103. (Pubitemid 44923648)
21. Miller G. J. ,Miller N. E. (1975) Plasma high-density lipoprotein concentration and the development of ischaemic heart disease. Lancet 1: 16-19.
22. Navab, M. , Imes, S. S. , Hama, S. Y. , Hough, G. P. , Ross, L. A. , Bork, R. W. , Valente, A. J. , Berliner, J. A. , Drinkwater, D. C. , Laks, H. & Fogelman, A. M. (1991) Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 88: 2039-2046.
23. Nicholls, S. J. , Dusting, G. J. , Cutri, B. Bao, S. , Drummond, G. R. , Rye K-A. , Barter, P. J. (2005) Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by periarterial collar in normocholesterolemic rabbits. Circulation 111: 1543-1550. (Pubitemid 40470651)
24. Rodrigo, L. , Mackness, B. , Durrington, P. N. , Hernandez, A. , Mackness, M. I. (2001) Hydrolysis of platelet-activating factor by human serum paraoxonase. Biochem J 354: 1-7. (Pubitemid 32183437)
25. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 362: 801-809.
26. Shih, D. M. , Gu, L. , Xia Y-R. , Navab, M. , Li, W-F. , Hama, S. , Castellani, L. W. , Furlong, C. E. , Costa, L. G. , Fogelman, A. M. , Lusis, A. J. (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394: 284-287. (Pubitemid 28335041)
27. Steinberg, D. , Parthasarathy, S. , Carew, T. E. , Khoo, J. C. and Witztum, J. L. (1989) Beyond cholesterol modifications of low-density lipoprotein that increase its atherogenicity. New Engl J Med 320: 915-924. (Pubitemid 19101597)
28. Watson, A. D. , Berliner, J. A. , Hama, S. Y. , La Du, B. N. , Fault, K. F. , Fogelman, A. M. , Navab, M. (1995)Protective effect of high density lipoprotein associated paraoxonase -Inhibition of the biological activity of minimally oxidised low-density lipoprotein. J Clin Invest 96: 2882-2891.